Heparin dosage during hemodialysis
Buccianti, G.; Pogliani, E.; Lorenz, M.; Cofrancesco, E.; Bianchi, M.L.; Cresseri, D.; Valenti, G.
Journal of Laboratory and Clinical Medicine 105(1): 139-140
1985
ISSN/ISBN: 0022-2143 PMID: 3155783 Document Number: 256059
Document emailed within 1 workday
Related Documents
Kruse-Blinkenberg, H.O.; Gormsen, J. 1976: Heparin concentration in blood pre- and postoperatively in surgical patients with low dosage heparin prophylaxis Ugeskrift for Laeger 138(12): 745-747Pelayo Alonso, R.; Cobo Sánchez, J.L.; de Buruaga Perea, A.S.áe.; Menezo Viadero, R.; Gándara Revuelta, M.; Aja Crespo, A.; Tovar Rincón, A. 2013: Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems Revista de Enfermeria 36(3): 8-12
Romão Júnior, J.E.; Fadil, M.A.; Zeratti, A.D.; Sabbaga, E. 1983: Hemodialysis without heparin Revista do Hospital das Clinicas 38(2): 70-72
Mortensen, S.A.; Remvig, L.; Als, O.S.; Andreasen, T. 1983: Antithrombin IIi (AT-III) and low dosage heparin therapy. the prognostic value of AT-IIi in acute myocardial infarction Ugeskrift for Laeger 145(14): 1056-1059
Simons, O. 1984: Heparin activity during hemodialysis Clinical Nephrology 21(4): 247
Späth, G.; Helber, M.U.; Eisele, R. 1985: Continuous long term heparin therapy--dosage problems using an Infusaid device Life Support Systems: the Journal of the European Society for Artificial Organs 3(1): 57-59
Kiil, J.; Kiil, J.; Axelsen, F. 1978: Heparin in low dosage as prophylaxis of postoperative pulmonary embolism and deep venous thrombosis Ugeskrift for Laeger 140(21): 1224-1230
Pittard, J.D. 2001: Heparin therapy in routine hemodialysis Nephrology News and Issues 15(5): 73-75
Braun, V.; Homann, B.; Sperling, M. 1986: Heparin dosage in long-term intravenous administration based on the example of vascular surgery patients Der Anaesthesist 35(5): 291-298
Janczak, D.; Pupka, A.; Skóra, J.; Szyber, P.ła.; Czapla, B.ło. 2010: The use of the heparin-bonded ePTFE grafts for needs of the hemodialysis Polimery W Medycynie 40(4): 35-39
Pristautz, H.; Katschnig, H.; Schenk, H.; Steinberger, R.; Pogglitsch, H.; Sailer, S. 1979: Effect of various parameters on heparin utilization in short-term hemodialysis Die Medizinische Welt 30(49): 1846-1848
Buccianti, G.; Valenti, G.; Lorenz, M.; Cresseri, D.; Strada, E.; Nazzari, M. 1990: Kinetics of anti-Xa activity during combined defibrotide-heparin administration in hemodialysis International Journal of Artificial Organs 13(7): 416-420
Henríquez, F.; Rodríguez, A.; Mora, C.; Sánchez-Deig, E.; Macía, M.; Navarro, J. 2006: Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 26(6): 734-737
Gavranić, B.B.; Basić-Jukić, N.; Kes, P. 2012: Patient who developed heparin-induced thrombocytopenia type Ii after 24 years on hemodialysis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 66(Suppl 2): 68-71
Matsuo, T.; Matsuo, M.; Ouga-Maruyama, S. 2001: Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)? Thrombosis and Haemostasis 86(4): 1115-1116
Benítez, M.; González Gómez, I.; González Carmelo, I.; Palma, A.; Cruz, S.; Rodríguez, E.; Amián, A.; Fernández M, F.; Merino, M.J.; Fernández G, F.; Suárez, C.; Onaindía, J.M.; González, J. 2007: Heparin immune thrombocytopenia in a hemodialysis patient. A case report. Literature review Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(6): 756-760
Ritschel, W.A.; Brady, M.E. 1979: Animal model for pharmacokinetic approach to individualized heparin dosage regimen for I.v. infusion by constant rate to achieve and maintain a desired clotting time Arzneimittel-Forschung 29(12): 1891-1894
Bechtold, H.; Kleist, P.; Landgraf, K.; Möser, K. 1994: Effect of low-dosage intravenous nitrate therapy on the anticoagulant effect of heparin Medizinische Klinik 89(7): 360-366
Leu, J.G.; Liou, H.H.; Wu, S.C.; Yang, W.C.; Huang, T.P.; Wu, S.C. 1998: Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis Journal of the Formosan Medical Association 97(1): 49-54
Eastwood, J.B.; Phillips, M.E.; Minty, P.; Gower, P.E.; Curtis, J.R. 1983: Heparin inactivation, acidosis and copper poisoning due to presumed acid contamination of water in a hemodialysis unit Clinical Nephrology 20(4): 197-201